dc.creatorPereira T.C.
dc.creatorLopes-Cendes I.
dc.date2012
dc.date2015-06-25T20:27:21Z
dc.date2015-11-26T15:23:55Z
dc.date2015-06-25T20:27:21Z
dc.date2015-11-26T15:23:55Z
dc.date.accessioned2018-03-28T22:32:49Z
dc.date.available2018-03-28T22:32:49Z
dc.identifierCentral Nervous System Agents In Medicinal Chemistry. , v. 12, n. 3, p. 217 - 232, 2012.
dc.identifier10.2174/187152412802430138
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84866651259&partnerID=40&md5=50b5100fce5bb68c813a4c9407ce4041
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/90733
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/90733
dc.identifier2-s2.0-84866651259
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1260562
dc.descriptionAn emerging new category of therapeutic agents based on ribonucleic acid has emerged and shown very promising in vitro, animal and pre-clinical results, known as small interfering RNAs (siRNAs), microRNAs mimics (miRNA mimics) and their derivates. siRNAs are small RNA molecules that promote potent and specific silencing of mutant, exogenous or aberrant genes through a mechanism known as RNA interference. These agents have called special attention to medicine since they have been used to experimentally treat a series of neurological conditions with distinct etiologies such as prion, viral, bacterial, fungal, genetic disorders and others. siRNAs have also been tested in other scenarios such as: control of anxiety, alcohol consumption, drug-receptor blockage and inhibition of pain signaling. Although in a much earlier stage, miRNAs mimics, anti-miRs and small activating RNAs (saRNAs) also promise novel therapeutic approaches to control gene expression. In this review we intend to introduce clinicians and medical researchers to the most recent advances in the world of siRNA- and miRNA-mediated gene control, its history, applications in cells, animals and humans, delivery methods (an yet unsolved hurdle), current status and possible applications in future clinical practice. © 2012 Bentham Science Publishers.
dc.description12
dc.description3
dc.description217
dc.description232
dc.descriptionNapoli, C., Lemieux, C., Jorgensen, R., Introduction of a chimeric chalcone synthase gene into petunia results in reversible cosuppression of homologous genes in trans (1990) Plant Cell, 2 (4), pp. 279-289
dc.descriptionWightman, B., Ha, I., Ruvkun, G., Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans (1993) Cell, 75 (5), pp. 855-862
dc.descriptionMeister, G., Tuschl, T., Mechanisms of gene silencing by doublestranded RNA (2004) Nature, 431, pp. 343-349
dc.descriptionElbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., Tuschl, T., Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells (2001) Nature, 411, pp. 494-498
dc.descriptionHolen, T., Amarzguioui, M., Wiiger, M.T., Babaie, E., Prydz, H., Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor (2002) Nucleic Acids Res., 30, pp. 1757-1766
dc.descriptionKhvorova, A., Reynolds, A., Jayasena, S.D., Functional siRNAs and miRNAs exhibit strand bias (2003) Cell, 115, pp. 209-216
dc.descriptionReynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W.S., Khvorova, A., Rational siRNA design for RNA interference (2004) Nat. Biotechnol., 22, pp. 326-330
dc.descriptionLayzer, J.M., McCaffrey, A.P., Tanner, A.K., Huang, Z., Kay, M.A., Sullenger, B.A., In vivo activity of nuclease-resistant siRNAs (2004) RNA, 10, pp. 766-771
dc.descriptionSchiffelers, R.M., Ansari, A., Xu, J., Zhou, Q., Tang, Q., Storm, G., Molema, G., Woodle, M.C., Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle (2004) Nucleic Acids Res., 32, pp. e149
dc.descriptionSoutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Vornlocher, H.P., Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs (2004) Nature, 432, pp. 173-178
dc.descriptionSchröfelbauer, B., Hakata, Y., Landau, N.R., HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1 (2007) Proc. Natl. Acad. Sci. U.S.A., 104, pp. 4130-4135
dc.descriptionFolkman, J., Tumor angiogenesis: Therapeutic implications (1971) N. Engl. J. Med., 285, pp. 1182-1186
dc.descriptionSun, L., Hui, A.M., Su, Q., Vortmeyer, A., Kotliarov, Y., Pastorino, S., Passaniti, A., Fine, H.A., Neuronal and gliomaderived stem cell factor induces angiogenesis within the brain (2006) Cancer Cell, 9, pp. 287-300
dc.descriptionPeters, K.G., Coogan, A., Berry, D., Marks, J., Iglehart, J.D., Kontos, C.D., Rao, P., Trogan, E., Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis (1998) Br. J. Cancer, 77, pp. 51-56
dc.descriptionGondi, C.S., Lakka, S.S., Dinh, D.H., Olivero, W.C., Gujrati, M., Rao, J.S., Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice (2007) Clin. Cancer Res., 13, pp. 4051-4060
dc.descriptionPyrko, P., Schönthal, A.H., Hofman, F.M., Chen, T.C., Lee, A.S., The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas (2007) Cancer Res., 67, pp. 9809-9816
dc.descriptionGoidts, V., Bageritz, J., Puccio, L., Nakata, S., Zapatka, M., Barbus, S., Toedt, G., Radlwimmer, B., RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival (2012) Oncogene, 31 (27), pp. 3235-3243
dc.descriptionWurdak, H., Zhu, S., Romero, A., Lorger, M., Watson, J., Chiang, C.Y., Zhang, J., Schultz, P.G., An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation (2010) Cell Stem Cell, 6, pp. 37-47
dc.descriptionSheng, Z., Li, L., Zhu, L.J., Smith, T.W., Demers, A., Ross, A.H., Moser, R.P., Green, M.R., A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications (2010) Nat Med., 16, pp. 671-677
dc.descriptionKim, Y.W., Liu, T.J., Koul, D., Tiao, N., Feroze, A.H., Wang, J., Powis, G., Yung, W.K., Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM (2011) Neuro Oncol., 13, pp. 367-375
dc.descriptionDavis, M.E., Zuckerman, J.E., Choi, C.H., Seligson, D., Tolcher, A., Alabi, C.A., Yen, Y., Ribas, A., Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles (2010) Nature, 464, pp. 1067-1070
dc.descriptionFluiter, K., Mook, O.R., Baas, F., The therapeutic potential of LNA-modified siRNAs: Reduction of off-target effects by chemical modification of the siRNA sequence (2009) Methods Mol. Biol., 487, pp. 189-203
dc.descriptionMusatov, S., Chen, W., Pfaff, D.W., Kaplitt, M.G., Ogawa, S., RNAi-mediated silencing of estrogen receptor {alpha} in the ventromedial nucleus of hypothalamus abolishes female sexual behaviors (2006) Proc. Natl. Acad. Sci. U.S.A., 103, pp. 10456-10460
dc.descriptionLasek, A.W., Janak, P.H., He, L., Whistler, J.L., Heberlein, U., Downregulation of mu opioid receptor by RNA interference in the ventral tegmental area reduces ethanol consumption in mice (2007) Genes Brain Behav., 6, pp. 728-735
dc.descriptionBahi, A., Boyer, F., Bussard, G., Dreyer, J.L., Silencing dopamine D3-receptors in the nucleus accumbens shell in vivo induces changes in cocaine-induced hyperlocomotion (2005) Eur. J. Neurosci., 21, pp. 3415-3426
dc.descriptionThakker, D.R., Natt, F., Hüsken, D., van der Putten, H., Maier, R., Hoyer, D., Cryan, J.F., siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain (2005) Mol. Psychiatry, 10, pp. 782-789
dc.descriptionChristoph, T., Grünweller, A., Mika, J., Schäfer, M.K., Wade, E.J., Weihe, E., Erdmann, V.A., Kurreck, J., Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo (2006) Biochem. Biophys. Res. Commun., 350, pp. 238-243
dc.descriptionKasama, S., Kawakubo, M., Suzuki, T., Nishizawa, T., Ishida, A., Nakayama, J., RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat (2007) Eur. J. Neurosci., 25, pp. 2956-2963
dc.descriptionAltier, C., Dale, C.S., Kisilevsky, A.E., Chapman, K., Castiglioni, A.J., Matthews, E.A., Evans, R.M., Zamponi, G.W., Differential role of N-type calcium channel splice isoforms in pain (2007) J. Neurosci, 27, pp. 6363-63673
dc.descriptionYang, C., Gagnon, D., Vachon, P., Tremblay, A., Levy, E., Massie, B., Michaud, J.L., Adenoviral-mediated modulation of Sim1 expression in the paraventricular nucleus affects food intake (2006) J. Neurosci., 26, pp. 7116-7120
dc.descriptionShishkina, G.T., Kalinina, T.S., Dygalo, N.N., Attenuation of μ2Aadrenergic receptor expression in neonatal rat brain by RNA interference or antisense oligonucleotide reduced anxiety in adulthood (2004) Neuroscience, 129, pp. 521-528
dc.descriptionHovatta, I., Tennant, R.S., Helton, R., Marr, R.A., Singer, O., Redwine, J.M., Ellison, J.A., Barlow, C., Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice (2005) Nature, 438, pp. 662-666
dc.descriptionMorrissey, D.V., Lockridge, J.A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Polisky, B., Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs (2005) Nature Biotechnol., 23, pp. 1002-1007
dc.descriptionJohnson, P.L., Truitt, W., Fitz, S.D., Minick, P.E., Dietrich, A., Sanghani, S., Träskman-Bendz, L., Shekhar, A., A key role for orexin in panic anxiety (2010) Nat. Med., 16, pp. 111-115
dc.descriptionKim, K.S., Lee, K.W., Baek, I.S., Lim, C.M., Krishnan, V., Lee, J.K., Nestler, E.J., Han, P.L., Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior (2008) J. Neurochem., 107, pp. 105-115
dc.descriptionBortolozzi, A., Castañé, A., Semakova, J., Santana, N., Alvarado, G., Cortés, R., Ferrés-Coy, A., Artigas, F., Selective siRNA-mediated suppression of 5-HT(1A) autoreceptors evokes strong anti-depressant-like effects (2012) Mol. Psychiatry, 17 (6), pp. 612-623
dc.descriptionBartel, D.P., MicroRNAs: Genomics, biogenesis, mechanism, and function (2004) Cell, 116, pp. 281-297
dc.descriptionSontheimer, E.J., Carthew, R.W., Silence from within: Endogenous siRNAs and miRNAs (2005) Cell, 122, pp. 9-12
dc.descriptionKiriakidou, M., Tan, G.S., Lamprinaki, S., De Planell-Saguer, M., Nelson, P.T., Mourelatos, Z., An mRNA m7G cap binding-like motif within human Ago2 represses translation (2007) Cell, 129, pp. 1141-1151
dc.descriptionMack, G.S., MicroRNA gets down to business (2007) Nat. Biotechnol., 25, pp. 631-638
dc.descriptionNiu, Q.W., Lin, S.S., Reyes, J.L., Chen, K.C., Wu, H.W., Yeh, S.D., Chua, N.H., (2006) Nat. Biotechnol., 24, p. 1420
dc.descriptionCalin, G.A., Dumitru, C.D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Croce, C.M., Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia (2002) Proc. Natl. Acad. Sci. U.S.A., 99, pp. 15524-15529
dc.descriptionShi, B., Sepp-Lorenzino, L., Prisco, M., Linsley, P., deAngelis, T., Baserga, R., Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells (2007) J. Biol. Chem., 282, pp. 32582-32590
dc.descriptionRobbins, M., Judge, A., Liang, L., McClintock, K., Yaworski, E., McLachlan, I., 2'-O-Methyl-modified RNAs act as TLR7 antagonists (2007) Mol. Ther., 15, pp. 1663-1669
dc.descriptionMusiyenko, A., Bitko, V., Barik, S., Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells (2008) J. Mol. Med., 86, pp. 313-322
dc.descriptionTsuda, N., Ishiyama, S., Li, Y., Ioannides, C.G., Abbruzzese, J.L., Chang, D.Z., Synthetic microRNA designed to target glioma associated antigen 1 transcription factor inhibits division and induces late apoptosis in pancreatic tumor cells (2006) Clin. Cancer Res., 12, pp. 6557-6564
dc.descriptionNan, Y., Han, L., Zhang, A., Wang, G., Jia, Z., Yang, Y., Yue, X., Kang, C., MiRNA-451 plays a role as tumor suppressor in human glioma cells (2010) Brain Res., 1359, pp. 14-21
dc.descriptionSchratt, G.M., Tuebing, F., Nigh, E.A., Kane, C.G., Sabatini, M.E., Kiebler, M., Greenberg, M.E., A brain-specific microRNA regulates dendritic spine development (2006) Nature, 439, pp. 283-289
dc.descriptionStern-Ginossar, N., Elefant, N., Zimmermann, A., Wolf, D.G., Saleh, N., Biton, M., Horwitz, E., Mandelboim, O., Host immune system gene targeting by a viral miRNA (2007) Science, 317, pp. 376-381
dc.descriptionLecellier, C.H., Dunoyer, P., Arar, K., Lehmann-Che, J., Eyquem, S., Himber, C., Saïb, A., Voinnet, O., A cellular microRNA mediates antiviral defense in human cells (2005) Science, 308, pp. 557-560
dc.descriptionSullivan, C.S., Grundhoff, A.T., Tevethia, S., Pipas, J.M., Ganem, D., SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells (2005) Nature, 435, pp. 682-686
dc.descriptionEbert, M.S., Neilson, J.R., Sharp, P.A., MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells (2007) Nat. Methods, 4, pp. 721-726
dc.descriptionEbert, M.S., Sharp, P.A., MicroRNA sponges: Progress and possibilities (2010) RNA, 16, pp. 2043-2050
dc.descriptionKluiver, J., Gibcus, J.H., Hettinga, C., Adema, A., Richter, M.K., Halsema, N., Slezak-Prochazka, I., van den Berg, A., Rapid generation of microRNA sponges for microRNA inhibition (2012) PLoS One, 7, pp. e29275
dc.descriptionFisher, M., Abramov, M., Van Aerschot, A., Xu, D., Juliano, R.L., Herdewijn, P., Inhibition of MDR1 expression with altritolmodified siRNAs (2007) Nucleic Acids. Res., 35, pp. 1064-1074
dc.descriptionLi, L.C., Okino, S.T., Zhao, H., Pookot, D., Place, R.F., Urakami, S., Enokida, H., Dahiya, R., Small dsRNAs induce transcriptional activation in human cells (2006) Proc. Natl. Acad. Sci. U.S.A., 103, pp. 17337-17342
dc.descriptionJanowski, B.A., Younger, S.T., Hardy, D.B., Ram, R., Huffman, K.E., Corey, D.R., Activating gene expression in mammalian cells with promoter-targeted duplex RNAs (2007) Nat. Chem. Biol., 3, pp. 166-173
dc.descriptionCheck, E., RNA interference: Hitting the on switch (2007) Nature, 448, pp. 855-858
dc.descriptionHuang, V., Qin, Y., Wang, J., Wang, X., Place, R.F., Lin, G., Lue, T.F., Li, L.C., RNAa is conserved in mammalian cells (2010) PLoS One, 5, pp. e8848
dc.descriptionPlace, R.F., Li, L.C., Pookot, D., Noonan, E.J., Dahiya, R., MicroRNA-373 induces expression of genes with complementary promoter sequences (2008) Proc. Natl. Acad. Sci. U.S.A., 105, pp. 1608-1613
dc.descriptionNoma, K., Sugiyama, T., Cam, H., Verdel, A., Zofall, M., Jia, S., Moazed, D., Grewal, S.I., RITS acts in cis to promote RNA interference-mediated transcriptional and post-transcriptional silencing (2004) Nat. Genet., 36, pp. 1174-1180
dc.descriptionMorris, K.V., Chan, S.W., Jacobsen, S.E., Looney, D.J., Small interfering RNA-induced transcriptional gene silencing in human cells (2004) Science, 305, pp. 1289-1292
dc.descriptionVastenhouw, N.L., Brunschwig, K., Okihara, K.L., Müller, F., Tijsterman, M., Plasterk, R.H., Gene expression: Long-term gene silencing by RNAi (2006) Nature, 24, pp. 442+882
dc.descriptionZhang, H.Y., Du, Q., Wahlestedt, C., Liang, Z., RNA Interference with chemically modified siRNA (2006) Curr. Top. Med. Chem., 6, pp. 893-900
dc.descriptionHoerter, J.A., Walter, N.G., Chemical modification resolves the asymmetry of siRNA strand degradation in human blood serum (2007) RNA, 13, pp. 1887-1893
dc.descriptionDowler, T., Bergeron, D., Tedeschi, A.L., Paquet, L., Ferrari, N., Damha, M.J., Improvements in siRNA properties mediated by 2'-deoxy-2'-fluoro-μ-d-arabinonucleic acid (FANA) (2006) Nucleic Acids Res., 34, pp. 1669-1675
dc.descriptionSipa, K., Sochacka, E., Kazmierczak-Baranska, J., Maszewska, M., Janicka, M., Nowak, G., Nawrot, B., Effect of base modifications on structure, thermodynamic stability, and gene silencing activity of short interfering RNA (2007) RNA, 13, pp. 1301-1316
dc.descriptionBirmingham, A., Anderson, E.M., Reynolds, A., Ilsley-Tyree, D., Leake, D., Fedorov, Y., Baskerville, S., Khvorova, A., 3' UTR seed matches, but not overall identity, are associated with RNAi offtargets (2006) Nat. Methods, 3, pp. 199-204
dc.descriptionLewis, B.P., Burge, C.B., Bartel, D.P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets (2005) Cell, 120, pp. 15-20
dc.descriptionGrimson, A., Farh, K.K., Johnston, W.K., Garrett-Engele, P., Lim, L.P., Bartel, D.P., MicroRNA targeting specificity in mammals: Determinants beyond seed pairing (2007) Mol. Cell, 27, pp. 91-105
dc.descriptionTowne, C., Setola, V., Schneider, B.L., Aebischer, P., Neuroprotection by gene therapy targeting mutant SOD1
dc.descriptionWatts, J.K., Choubdar, N., Sadalapure, K., Robert, F., Wahba, A.S., Pelletier, J., Pinto, B.M., Damha, M.J., 2'-Fluoro-4'-thioarabino-modified oligonucleotides: Conformational switches linked to siRNA activity (2007) Nucleic Acids Res., 35, pp. 1441-1451
dc.descriptionGaglione, M., Messere, A., Recent progress in chemically modified siRNAs (2010) Mini Rev. Med. Chem., 10 (7), pp. 578-595
dc.descriptionBrummelkamp, T.R., Bernards, R., Agami, R., A system for stable expression of short interfering RNAs in mammalian cells (2002) Science, 296, pp. 550-553
dc.descriptionHohjoh, H., Enhancement of RNAi activity by improved siRNA duplexes (2004) FEBS Lett., 557, pp. 193-198
dc.descriptionKim, D.H., Behlke, M.A., Rose, S.D., Chang, M.S., Choi, S., Rossi, J.J., Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy (2005) Nat. Biotechnol., 23, pp. 222-226
dc.descriptionYang, D., Buchholz, F., Huang, Z., Goga, A., Chen, C.Y., Brodsky, F.M., Bishop, J.M., Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells (2002) Proc. Natl. Acad. Sci. U.S.A., 99, pp. 9942-9947
dc.descriptionSun, X., Rogoff, H.A., Li, C.J., Asymmetric RNA duplexes mediate RNA interference in mammalian cells (2008) Nat. Biotechnol., 26 (12), pp. 1379-1382
dc.descriptionChu, C.Y., Rana, T.M., Potent RNAi by short RNA triggers (2008) RNA, 14 (9), pp. 1714-1719
dc.descriptionBolcato-Bellemin, A.L., Bonnet, M.E., Creusat, G., Erbacher, P., Behr, J.P., Sticky overhangs enhance siRNA-mediated gene silencing (2007) Proc. Natl. Acad. Sci. U.S.A., 104 (41), pp. 16050-16055
dc.descriptionSeyhan, A.A., Vlassov, A.V., Johnston, B.H., RNA interference from multimeric shRNAs generated by rolling circle transcription (2006) Oligonucleotides, 16 (4), pp. 353-363
dc.descriptionCaplen, N.J., Taylor, J.P., Statham, V.S., Tanaka, F., Fire, A., Morgan, R.A., Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference (2002) Hum. Mol. Genet., 11, pp. 175-184
dc.descriptionKoldehoff, M., Steckel, N.K., Beelen, D.W., Elmaagacli, A.H., Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia (2007) Clin. Exp. Med., 7 (2), pp. 47-55
dc.descriptionKoldehoff, M., Elmaagacli, A.H., Therapeutic targeting of gene expression by siRNAs directed against BCR-ABL transcripts in a patient with imatinib-resistant chronic myeloid leukemia (2009) Methods Mol. Biol., 487, pp. 451-466
dc.descriptionDavis, M.E., The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: From concept to clinic (2009) Mol. Pharm., 6 (3), pp. 659-668
dc.descriptionLeachman, S.A., Hickerson, R.P., Schwartz, M.E., Bullough, E.E., Hutcherson, S.L., Boucher, K.M., Hansen, C.D., Kaspar, R.L., First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder (2010) Mol. Ther., 18 (2), pp. 442-446
dc.descriptionDavis, M.E., Zuckerman, J.E., Choi, C.H., Seligson, D., Tolcher, A., Alabi, C.A., Yen, Y., Ribas, A., Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles (2010) Nature, 464, pp. 1067-1070
dc.descriptionBahi, A., Boyer, F., Kolira, M., Dreyer, J.L., In vivo gene silencing of CD81 by lentiviral expression of small interference RNAs suppresses cocaine-induced behaviour (2005) J. Neurochem., 92, pp. 1243-1255
dc.descriptionPfeifer, A., Eigenbrod, S., Al-Khadra, S., Hofmann, A., Mitteregger, G., Moser, M., Bertsch, U., Kretzschmar, H., Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice (2006) J. Clin. Invest., 116, pp. 3204-3210
dc.descriptionCarmell, M.A., Zhang, L., Conklin, D.S., Hannon, G.J., Rosenquist, T.A., Germline transmission of RNAi in mice (2003) Nat. Struct. Biol., 10, pp. 91-92
dc.descriptionChen, Q., Butler, D., Querbes, W., Pandey, R.K., Ge, P., Maier, M.A., Zhang, L., Sah, D.W., Lipophilic siRNAs mediate efficient gene silencing in oligodendrocytes with direct CNS delivery (2010) J. Control Release, 144, pp. 227-232
dc.descriptionYang, T., Choi, M.K., Cui, F.D., Lee, S.J., Chung, S.J., Shim, C.K., Kim, D.D., Antitumor effect of paclitaxel-loaded PEGylated immunoliposomes against human breast cancer cells (2007) Pharm. Res., 24, pp. 2402-2411
dc.descriptionBoado, R.J., Blood-brain barrier transport of non-viral gene and RNAi therapeutics (2007) Pharm. Res., 24, pp. 1772-1787
dc.descriptionZhang, Y., Zhang, Y.F., Bryant, J., Charles, A., Boado, R.J., Pardridge, W.M., Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer (2004) Clin. Cancer Res., 10, pp. 3667-3677
dc.descriptionKumar, P., Wu, H., McBride, J.L., Jung, K.E., Kim, M.H., Davidson, B.L., Lee, S.K., Manjunath, N., Transvascular delivery of small interfering RNA to the central nervous system (2007) Nature, 448, pp. 39-43
dc.descriptionAlvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., Wood, M.J., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes (2011) Nat. Biotechnol., 29, pp. 341-345
dc.descriptionCastilla, J., Saá, P., Soto, C., Detection of prions in blood (2005) Nat. Med., 11, pp. 982-985
dc.descriptionDaude, N., Marella, M., Chabry, J., Specific inhibition of pathological prion protein accumulation by small interfering RNAs (2003) J. Cell Sci., 116, pp. 2775-2779
dc.descriptionAtarashi, R., Moore, R.A., Sim, V.L., Hughson, A.G., Dorward, D.W., Onwubiko, H.A., Priola, S.A., Caughey, B., Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein (2007) Nat. Methods, 4, pp. 645-650
dc.descriptionPulford, B., Reim, N., Bell, A., Veatch, J., Forster, G., Bender, H., Meyerett, C., Zabel, M.D., Liposome-siRNA-peptide complexes cross the bloodbrain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures (2010) PLoS One, 5, pp. e11085
dc.descriptionLeucht, C., Simoneau, S., Rey, C., Vana, K., Rieger, R., Lasmézas, C.I., Weiss, S., The 37 kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells (2003) EMBO Rep., 4, pp. 290-295
dc.descriptionPflanz, H., Vana, K., Mitteregger, G., Pace, C., Messow, D., Sedlaczek, C., Nikles, D., Weiss, S.F., Microinjection of lentiviral vectors expressing small interfering RNAs directed against laminin receptor precursor mRNA prolongs the pre-clinical phase in scrapie-infected mice (2009) J. Gen. Virol., 90, pp. 269-274
dc.descriptionLudewigs, H., Zuber, C., Vana, K., Nikles, D., Zerr, I., Weiss, S., Therapeutic approaches for prion disorders (2007) Expert Rev. Anti Infect. Ther., 5, pp. 613-630
dc.descriptionZafar, S., von Ahsen, N., Oellerich, M., Zerr, I., Schulz-Schaeffer, W.J., Armstrong, V.W., Asif, A.R., Proteomics approach to identify the interacting partners of cellular prion protein and characterization of Rab7a interaction in neuronal cells (2011) J. Proteome Res., 10, pp. 3123-3135
dc.descriptionJacque, J.M., Triques, K., Stevenson, M., Modulation of HIV-1 replication by RNA interference (2002) Nature, 418, pp. 435-438
dc.descriptionWiebusch, L., Truss, M., Hagemeier, C., Inhibition of human cytomegalovirus replication by small interfering RNAs (2004) J. Gen. Virol., 85, pp. 179-184
dc.descriptionPalliser, D., Chowdhury, D., Wang, Q.Y., Lee, S.J., Bronson, R.T., Knipe, D.M., Lieberman, J., An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection (2006) Nature, 439, pp. 89-94
dc.descriptionGitlin, L., Karelsky, S., Andino, R., Short interfering RNA confers intracellular antiviral immunity in human cells (2002) Nature, 418, pp. 430-434
dc.descriptionNovina, C.D., Murray, M.F., Dykxhoorn, D.M., Beresford, P.J., Riess, J., Lee, S.K., Collman, R.G., Sharp, P.A., siRNA-directed inhibition of HIV-1 infection (2002) Nat. Med., 8, pp. 681-686
dc.descriptionArteaga, H.J., Hinkula, J., van Dijk-Härd, I., Dilber, M.S., Wahren, B., Christensson, B., Mohamed, A.J., Smith, C.I., Choosing CCR5 or Rev siRNA in HIV-1 (2003) Nat. Biotechnol., 21, pp. 230-231
dc.descriptionRyo, A., Tsurutani, N., Ohba, K., Kimura, R., Komano, J., Nishi, M., Soeda, H., Yamamoto, N., SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag (2008) Proc. Natl. Acad. Sci. U.S.A., 105, pp. 294-299
dc.descriptionBortolamiol, D., Pazhouhandeh, M., Marrocco, K., Genschik, P., Ziegler-Graff, V., The Polerovirus F box protein P0 targets ARGONAUTE1 to suppress RNA silencing (2007) Curr. Biol., 17, pp. 1615-1621
dc.descriptionCullen, B.R., Is RNA interference involved in intrinsic antiviral immunity in mammals? (2006) Nat. Immunol., 7, pp. 563-567
dc.descriptionBivalkar-Mehla, S., Vakharia, J., Mehla, R., Abreha, M., Kanwar, J.R., Tikoo, A., Chauhan, A., Viral RNA silencing suppressors (RSS): Novel strategy of viruses to ablate the host RNA interference (RNAi) defense system (2011) Virus Res., 155, pp. 1-9
dc.descriptionChurikov, N.A., Chistiakova, L.G., Zavil'gel'ski, G.B., Manukhov, I.V., RNA interference in Escherichia coli cells: The expression of molecules that are complementary to the lon gene mRNA in parallel orientation (2000) Genetika, 36, pp. 23-27. , In Russian
dc.descriptionYanagihara, K., Tashiro, M., Fukuda, Y., Ohno, H., Higashiyama, Y., Miyazaki, Y., Hirakata, Y., Kohno, S., Effects of short interfering RNA against methicillin-resistant Staphylococcus aureus coagulase in vitro and in vivo (2006) J. Antimicrob. Chemother., 57, pp. 122-126
dc.descriptionSchubert-Unkmeir, A., Konrad, C., Slanina, H., Czapek, F., Hebling, S., Frosch, M., Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: A role for MMP-8 (2010) PLoS Pathog., 6, pp. e1000874
dc.descriptionLong, M., Huang, S.H., Wu, C.H., Shackleford, G.M., Jong, A., Lipid raft/caveolae signaling is required for Cryptococcus neoformans invasion into human brain microvascular endothelial cells (2012) J. Biomed. Sci., 19, p. 19
dc.descriptionHuang, S.H., Long, M., Wu, C.H., Kwon-Chung, K.J., Chan, Y.C., Chi, F., Lee, S., Jong, A., Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells is mediated through the lipid rafts-endocytic pathway via the dual specificity tyrosine phosphorylation-regulated kinase 3 (DYRK3) (2011) J. Biol. Chem., 286, pp. 34761-34769
dc.descriptionChen, Y., Chen, J., Wen, H., Gao, P., Wang, J., Zheng, Z., Gu, J., S100A10 downregulation inhibits the phagocytosis of Cryptococcus neoformans by murine brain microvascular endothelial cells (2011) Microb. Pathog., 51, pp. 96-100
dc.descriptionQin, Q.M., Luo, J., Lin, X., Pei, J., Li, L., Ficht, T.A., de Figueiredo, P., Functional analysis of host factors that mediate the intracellular lifestyle of Cryptococcus neoformans (2011) PLoS Pathog., 7, pp. e1002078
dc.descriptionKarlas, A., Machuy, N., Shin, Y., Pleissner, K.P., Artarini, A., Heuer, D., Becker, D., Meyer, T.F., Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication (2010) Nature, 463, pp. 818-822
dc.descriptionCronin, S.J., Nehme, N.T., Limmer, S., Liegeois, S., Pospisilik, J.A., Schramek, D., Leibbrandt, A., Penninger, J.M., Genome-wide RNAi screen identifies genes involved in intestinal pathogenic bacterial infection (2009) Science, 325, pp. 340-343
dc.descriptionKumar, D., Nath, L., Kamal, M.A., Varshney, A., Jain, A., Singh, S., Rao, K.V., Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis (2010) Cell., 140, pp. 731-743
dc.descriptionAbdulla, M.H., O'Brien, T., Mackey, Z.B., Sajid, M., Grab, D.J., McKerrow, J.H., RNA interference of Trypanosoma brucei cathepsin B and L affects disease progression in a mouse model (2008) PLoS Negl. Trop. Dis., 2, pp. e298
dc.descriptionPereira, T.C., Pascoal, V.D., Marchesini, R.B., Maia, I.G., Magalhães, L.A., Zanotti-Magalhães, E.M., Lopes-Cendes, I., Schistosoma mansoni: Evaluation of an RNAi-based treatment targeting HGPRTase gene (2008) Exp. Parasitol., 118, p. 619
dc.descriptionChandramohanadas, R., Davis, P.H., Beiting, D.P., Harbut, M.B., Darling, C., Velmourougane, G., Lee, M.Y., Greenbaum, D.C., Apicomplexan parasites co-opt host calpains to facilitate their escape from infected cells (2009) Science, 324, pp. 794-797
dc.descriptionKasinathan, R.S., Morgan, W.M., Greenberg, R.M., Genetic knockdown and pharmacological inhibition of parasite multidrug resistance transporters disrupts egg production in Schistosoma mansoni (2011) PLoS Negl. Trop. Dis., 5, pp. e1425
dc.descriptionKumar, S., Molina-Cruz, A., Gupta, L., Rodrigues, J., Barillas-Mury, C., A peroxidase/dual oxidase system modulates midgut epithelial immunity in Anopheles gambiae (2010) Science, 327, pp. 1644-1648
dc.descriptionGrab, D.J., Garcia-Garcia, J.C., Nikolskaia, O.V., Kim, Y.V., Brown, A., Pardo, C.A., Zhang, Y., Dumler, J.S., Protease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cells (2009) PLoS Negl. Trop. Dis., 3, pp. e479
dc.descriptionMaxwell, M.M., Pasinelli, P., Kazantsev, A.G., Brown Jr., R.H., RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells (2004) Proc. Natl. Acad. Sci. U.S. A, 101, pp. 3178-3183
dc.descriptionRaoul, C., Abbas-Terki, T., Bensadoun, J.C., Guillot, S., Haase, G., Szulc, J., Henderson, C.E., Aebischer, P., Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS (2005) Nat. Med., 11, pp. 423-428
dc.descriptionRalph, G.S., Radcliffe, P.A., Day, D.M., Carthy, J.M., Leroux, M.A., Lee, D.C., Wong, L.F., Azzouz, M., Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model (2005) Nat. Med., 11, pp. 429-433
dc.descriptionSaito, Y., Yokota, T., Mitani, T., Ito, K., Anzai, M., Miyagishi, M., Taira, K., Mizusawa, H., Transgenic small interfering RNA halts amyotrophic lateral sclerosis in a mouse model (2005) J. Biol. Chem., 280, pp. 42826-42830
dc.descriptionXia, X., Zhou, H., Huang, Y., Xu, Z., Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo (2006) Neurobiol. Dis., 23, pp. 578-586
dc.descriptionLocatelli, F., Corti, S., Papadimitriou, D., Fortunato, F., Del Bo, R., Donadoni, C., Nizzardo, M., Comi, G.P., Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice (2007) Ann. Neurol., 62, pp. 81-92
dc.descriptionXie, J., Awad, K.S., Guo, Q., RNAi knockdown of Par-4 inhibits neurosynaptic degeneration in ALS-linked mice (2005) J. Neurochem., 92, pp. 59-71
dc.descriptionGoehler, H., Lalowski, M., Stelzl, U., Waelter, S., Stroedicke, M., Worm, U., Droege, A., Wanker, E.E., A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease (2004) Mol. Cell., 15, pp. 853-865
dc.descriptionQiu, Z., Norflus, F., Singh, B., Swindell, M.K., Buzescu, R., Bejarano, M., Chopra, R., Hersch, S.M., Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective (2006) J. Biol. Chem., 281, pp. 16672-16680
dc.descriptionHarper, S.Q., Staber, P.D., He, X., Eliason, S.L., Martins, I.H., Mao, Q., Yang, L., Davidson, B.L., RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model (2005) Proc. Natl. Acad. Sci. U.S.A., 102, p. 5820
dc.descriptionWang, Y.L., Liu, W., Wada, E., Murata, M., Wada, K., Kanazawa, I., Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA (2005) Neurosci. Res., 53, pp. 241-249
dc.descriptionRodriguez-Lebron, E., Denovan-Wright, E.M., Nash, K., Lewin, A.S., Mandel, R.J., Intrastriatal rAAV-mediated delivery of antihuntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice (2005) Mol. Ther., 12, pp. 618-633
dc.descriptionMachida, Y., Okada, T., Kurosawa, M., Oyama, F., Ozawa, K., Nukina, N., rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse (2006) Biochem. Biophys. Res. Commun., 343, pp. 190-197
dc.descriptionHuang, B., Schiefer, J., Sass, C., Landwehrmeyer, G.B., Kosinski, C.M., Kochanek, S., High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo (2007) Hum. Gene Ther., 18, pp. 303-311
dc.descriptionDiFiglia, M., Sena-Esteves, M., Chase, K., Sapp, E., Pfister, E., Sass, M., Yoder, J., Aronin, N., Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits (2007) Proc. Natl. Acad. Sci. U.S.A., 104, pp. 17204-17209
dc.descriptionHorvath, L., van Marion, I., Taï, K., Nielsen, T.T., Lundberg, C.J., Knockdown of GAD67 protein levels normalizes neuronal activity in a rat model of Parkinson's disease (2011) Gene Med., 13, pp. 188-197
dc.descriptionde Yñigo-Mojado, L., Martín-Ruíz, I., Sutherland, J.D., Efficient allele-specific targeting of LRRK2 R1441 mutations mediated by RNAi (2011) PLoS One., 6, pp. e21352
dc.descriptionGerard, M., Deleersnijder, A., Daniëls, V., Schreurs, S., Munck, S., Reumers, V., Pottel, H., Baekelandt, V., Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology (2010) J. Neurosci., 30, pp. 2454-2463
dc.descriptionHe, G., Luo, W., Li, P., Remmers, C., Netzer, W.J., Hendrick, J., Bettayeb, K., Greengard, P., Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease (2010) Nature, 467, pp. 95-98
dc.descriptionLópez-Tobón, A., Castro-Álvarez, J.F., Piedrahita, D., Boudreau, R.L., Gallego-Gómez, J.C., Cardona-Gómez, G.P., Silencing of CDK5 as potential therapy for Alzheimer's disease (2011) Rev. Neurosci., 22, pp. 143-152
dc.descriptionHu, J., Gagnon, K.T., Liu, J., Watts, J.K., Syeda-Nawaz, J., Bennett, C.F., Swayze, E.E., Corey, D.R., Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAs (2011) Biol. Chem., 392, pp. 315-325
dc.descriptionAlves, S., Nascimento-Ferreira, I., Dufour, N., Hassig, R., Auregan, G., Nóbrega, C., Brouillet, E., de Almeida, L.P., Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: No role for wild-type ataxin-3? (2010) Hum. Mol. Genet., 19, pp. 2380-2394
dc.descriptionNakano, I., Masterman-Smith, M., Saigusa, K., Paucar, A.A., Horvath, S., Shoemaker, L., Watanabe, M., Kornblum, H.I., Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells (2008) J. Neurosci. Res., 86, p. 48
dc.descriptionHorvath, S., Zhang, B., Carlson, M., Lu, K.V., Zhu, S., Felciano, R.M., Laurance, M.F., Mischel, P.S., Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target (2006) Proc. Natl. Acad. Sci. U.S.A., 103, pp. 17402-17407
dc.descriptionPatry, C., Bouchard, L., Labrecque, P., Gendron, D., Lemieux, B., Toutant, J., Lapointe, E., Chabot, B., Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines (2003) Cancer Res., 63, pp. 7679-7688
dc.relationCentral Nervous System Agents in Medicinal Chemistry
dc.rightsfechado
dc.sourceScopus
dc.titleEmerging Rna-based Drugs: Sirnas, Micrornas And Derivates
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución